Evening Market Recap
AstraZeneca Puts $270 Million Cambridge Expansion On Hold Amid Shifting U.K. Business Climate
Trump Issues Ultimatum to Pharma CEOs: Cut Drug Prices Within 60 Days or Face Action
AstraZeneca Unveils $50 Billion U.S. Manufacturing Push in Bid to Expand Market Share and Counter Tariff Threats
Summit Therapeutics Shares Surge on Reported $15B AstraZeneca Deal Talks
FDA Approves Merck’s RSV Shot for Infants, Intensifying Competition with Sanofi and AstraZeneca
Pump Radar
Stock Alerts